Associations of blood levels of insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-3 in schizophrenic Arab subjects

Clinical Chemistry and Laboratory Medicine

Volumn 45, Issue 9, 2007, Pages 1229-1231

  O Akanji, Abayomi ^a   U Ohaeri, Jude ^b   A Al Shammri, Suhail ^a   R Fatania, Hasmukh ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

^b Psychological Medicine Hospital Kuwait   (Kuwait)

Author keywords

Arabs; Atherogenic dyslipidaemia; IGF II; Insulin like growth factor binding protein (IGFBP); Insulin like growth factor I (IGF I); Schizophrenia

Indexed keywords

APOLIPOPROTEIN B; BENZATROPINE; HALOPERIDOL; LOW DENSITY LIPOPROTEIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TRIHEXYPHENIDYL; URIC ACID;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DEMOGRAPHY; DRUG RESPONSE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; AGED; ARABS; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; KUWAIT; LIPOPROTEINS; MALE; MIDDLE AGED; SCHIZOPHRENIA;

EID: 34548577116     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2007.265     Document Type: Article

References (13)

1. Holly J. Physiology of the IGF system. Novartis Found Symp 2004;262:19-35.
2. Firth SM, Baxter RC. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 2002;23:824-54.
3. Abel KM. Foetal origins of schizophrenia: testable hypotheses of genetic and environmental influences. Br J Psychiatr 2004;184:383-5.
4. Gunnell D, Holly JM. Do insulin-like growth factors underlie associations of birth complications, fetal and pre-adult growth with schizophrenia? Schizophrenia Res 2004;67:309-11.
5. Gluckman PD, Guan J, Williams C, Scheepens A, Zhang R, Bennet L, et al. Asphyxial brain injury - the role of the IGF system. Mol Cell Endocrinol 1998;140:95-9.
6. Gunnell D, Holly JM. Insulin-like growth factors, insulin resistance and schizophrenia. Br J Psychiatr 2004;185:353-4.
7. World Health Organization. International statistical classification of diseases and related health problems. 10th revision. Geneva: World Health Organization, 1992.
8. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association, 1994.
9. Wing JK, Babor T, Brugha T, Burke J, Cooper JE, Giel R, et al. SCAN - schedules for clinical assessment in neuropsychiatry. Arch Gen Psychiatr 1990;47:589-93.
10. Gluckman PD, Pinal SC. Regulation of fetal growth by the somatotrophic axis. J Nutr 2003;133(Suppl 2):S1741-6.
11. Ludwig T, Eggenschwiler J, Fisher P, D'Ercole AJ, Davenport ML, Efstratiadis A. Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. Dev Biol 1996;177:517-35.
12. Vu TH, Jirtle RL, Hoffman AR. Cross-species clues of an epigenetic imprinting regulatory code for the IGF2R gene. Cytogenet Genome Res 2006;113:202-8.
13. Heald A, Kaushal K, Anderson S, Redpath M, Durrington PN, Selby PL, et al. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk. Gynecol Endocrinol 2005;20:176-82.